Levering W H, van den Beemd R, te Marvelde J G, van Beers W A, Hooijkaas H, Sintnicolaas K, Gratama J W
Laboratory for Histocompatibility and Immunogenetics, Blood Bank Rotterdam, The Netherlands.
Cytometry. 2000 Apr 15;42(2):95-105.
A biannual external quality assurance (EQA) scheme for flow cytometric typing of the HLA-B27 antigen is operational in The Netherlands and Belgium since 1995. We report here on the results of the first seven send-outs to which 36 to 47 laboratories participated. With the send-out, four specimens from blood bank donors, who had been typed for HLA Class I antigens by complement-dependent cytotoxicity, were distributed. Subtyping of the HLA-B27 allele was performed by PCR-SSP. Ten samples were HLA-B27(pos) (all HLA-B*2705) and 18 were HLA-B27(neg). For flow cytometry, the most widely monoclonal antibody (MoAb) used was FD705, followed by GS145.2 and ABC-m3. The majority of laboratories used more than 1 anti-HLA-B27 MoAb for typing. The HLA-B27(pos) samples were correctly classified as positive by the large majority of participants (median 95%; range 85% to 100% per send out); some participants considered further typing necessary and misclassification as negative was only sporadically seen. The classification of HLA-B27(neg) samples as negative was less straightforward. Ten samples were correctly classified as such by 97% (82% to 100%) of the participants, whereas 64% (range 53% to 70%) of the participants classified the remaining eight samples as HLA-B27(neg). There was no significant prevalence of a particular HLA-B allele among these eight "poor concordancy" samples as compared to the ten "good concordancy" samples. Inspection of the reactivity patterns of the individual MoAb with HLA-B27(neg) samples revealed that ABC-m3 showed very little cross-reactivity apart from its well-known cross-reactivity with HLA-B7, whereas the cross-reactivity patterns of GS145.2 and FD705 were more extensive. The small sample size (n = 18) and the distribution of HLA-B alleles other than HLA-B27 did not allow assignment of specificities to these cross-reactions. Finally, we showed that standardized interpretation of the combined results of two anti-HLA-B27 MoAb reduced the frequency of false-positive conclusions on HLA-B27(neg) samples. In this series, the lowest frequency of false-positive assignments was observed with the combination of the FD705 and ABC-m3 MoAb.
自1995年以来,荷兰和比利时开展了一项针对HLA - B27抗原流式细胞术分型的年度两次外部质量保证(EQA)计划。我们在此报告前七次发放检测的结果,有36至47个实验室参与。在每次发放检测中,分发了4份来自血库供者的标本,这些标本之前已通过补体依赖细胞毒性法进行了HLA I类抗原分型。HLA - B27等位基因的亚型分型通过PCR - SSP进行。其中10份样本为HLA - B27阳性(均为HLA - B*2705),18份为HLA - B27阴性。对于流式细胞术,使用最广泛的单克隆抗体(MoAb)是FD705,其次是GS145.2和ABC - m3。大多数实验室使用不止一种抗HLA - B27 MoAb进行分型。绝大多数参与者(每次发放检测的中位数为95%;范围为85%至100%)将HLA - B27阳性样本正确分类为阳性;一些参与者认为需要进一步分型,仅偶尔出现误分类为阴性的情况。将HLA - B27阴性样本分类为阴性则不那么直接。97%(82%至100%)的参与者将10份样本正确分类为阴性,而64%(范围为53%至70%)的参与者将其余8份样本分类为HLA - B27阴性。与10份“一致性良好”的样本相比,这8份“一致性较差”的样本中没有特定HLA - B等位基因明显占优情况。检查各个MoAb与HLA - B27阴性样本的反应模式发现,ABC - m3除了与HLA - B7有众所周知的交叉反应外,交叉反应非常少,而GS145.2和FD705的交叉反应模式更广泛。样本量小(n = 18)以及HLA - B27以外的HLA - B等位基因分布情况不允许对这些交叉反应确定特异性。最后,我们表明对两种抗HLA - B27 MoAb的联合结果进行标准化解读可降低HLA - B27阴性样本假阳性结论的频率。在这个系列中,使用FD705和ABC - m3 MoAb组合时观察到的假阳性判定频率最低。